VIEWPOINTS PharmaShots Interview: Takeda’s Chris Arendt Shares Insight on the Data of Alunbrig Presented at ESMO 2021BySenior EditorNovember 22, 20210Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in October 2021BySenior EditorNovember 18, 20210Comments
VIEWPOINTS PharmaShots Interview: NervGen’s Paul Brennan Shares Insights on NVG-291 and its Interim Data for the Treatment of Neurodegenerative DiseasesBySenior EditorNovember 17, 20210Comments
VIEWPOINTS PharmaShots Interview: Paracrine’s Christopher J. Calhoun Shares Insight on the First Autologous, Device-Based Cell Therapy PlatformBySenior EditorNovember 16, 20210Comments
VIEWPOINTS PharmaShots Interview: Genmab’s Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical CancerBySenior EditorNovember 15, 20210Comments
VIEWPOINTS PharmaShots Interview: Janssen’s Lloyd Miller Shares Insight on the Data of Tremfya (guselkumab) Presented at EADV 2021BySenior EditorNovember 10, 20210Comments
VIEWPOINTS PharmaShots Interview: Thermo Fisher Scientific Garret Hampton Shares Insight on the Multiyear Agreement with AstraZeneca for NGS-based CDxBySenior EditorNovember 9, 20210Comments
VIEWPOINTS PharmaShots Interview: Dr. Trevor Feinstein and BeyondSpring’s Dr. Lan Huang Shares Insight on the Data of Plinabulin + Docetaxel for NSCLC with EGFR Wild TypeBySenior EditorNovember 8, 20210Comments
